(FTV) Fortive Corporation Company Overview

What does Fortive Corporation do?

Fortive Corporation is a focused industrial technology and healthcare workflow company traded on the New York Stock Exchange under the ticker FTV. After the June 2025 separation of its Precision Technologies business into Ralliant, Fortive is now organized around two continuing segments: Intelligent Operating Solutions and Advanced Healthcare Solutions. Its official reporting describes a company that designs, develops, manufactures, and markets products, software, and services used in mission-critical workflows across manufacturing, healthcare, utilities, energy infrastructure, communications, facilities, safety, and compliance.

Which businesses define Fortive now?

The post-separation company is best understood as a portfolio of specialized operating companies rather than as a single product line. Intelligent Operating Solutions includes tools, connected instrumentation, safety systems, facility and asset lifecycle software, and workflow platforms associated with brands such as Fluke, Industrial Scientific, Accruent, Gordian, ServiceChannel, and Intelex. Advanced Healthcare Solutions focuses on sterilization, instrument tracking, biomedical test tools, radiation safety and dosimetry, and clinical productivity software associated with brands such as ASP, Censis, Fluke Biomedical, Landauer, and Provation. Fortive's 2025 Annual Report frames these activities as essential technologies that keep customer environments safe and productive.

Customer problem solved. Fortive sells into workflows where accuracy, uptime, compliance, safety, and auditability matter more than low sticker price. A facilities manager may need software to control repair spending across thousands of sites; a hospital may need traceability for sterile instruments; an electrical engineer may need trusted measurement equipment; and an environmental, health, and safety team may need gas detection and compliance records. That makes Fortive more workflow-oriented than a simple equipment manufacturer: the value proposition is the reduction of downtime, rework, safety incidents, regulatory gaps, and hidden operating costs.

How does Fortive make money?

Fortive makes money through a mix of product and software sales, recurring services, subscriptions, support contracts, and workflow solutions. In FY2025, the company reported $4.16B of continuing sales. Products and software generated $3.34B, or about 80% of sales, while services generated $817.8M, or about 20%. The important nuance is that the product sale often sits inside a larger lifecycle: installed instruments require calibration, service, software, compliance records, or connected workflows, and healthcare systems value traceability and uptime after the initial purchase.

Which segment generates the most revenue?

How recurring is the model?

Fortive does not disclose one simple software-style ARR number for the whole company, but management's June 2025 post-separation communication described the new Fortive as having approximately 50% recurring revenue. The FY2025 RPO disclosure supports that direction: $840.7M of remaining performance obligations were outstanding at December 31, 2025, with 75% expected to be fulfilled within two years and 90% within three years. That is not the same as a pure SaaS model, yet it shows that the company has meaningful contracted visibility beyond one-time hardware shipments.

Which markets and customer groups matter most?

Fortive's end-market profile is diversified, but not random. Healthcare and industrial/manufacturing customers are the largest demand pools, followed by energy and infrastructure, government, retail, and other markets. This mix explains why the company is exposed to both capital-spending cycles and resilience-oriented compliance workflows. In FY2025, Fortive also reported that about 44% of sales came from customers outside the United States, making foreign exchange, tariffs, local regulation, and regional demand part of the business model rather than side issues.

Where does Fortive sell geographically?

Which end markets shape demand?

What does Fortive’s latest quarter show?

The latest official reporting package is Fortive's Q1 2026 results for the quarter ended April 3, 2026. The company reported revenue of $1.069B, up 7.7% on a reported basis and 5.3% on a core basis. Management also noted a roughly 150 basis-point tailwind from extra selling days. GAAP net earnings from continuing operations were $136M, GAAP diluted EPS was $0.44, and adjusted diluted EPS was $0.70. The Q1 2026 earnings release also gave FY2026 adjusted diluted EPS guidance of $2.90 to $3.00.

What does the latest quarter say about demand?

Q1 2026 looked stronger than Fortive's FY2025 growth rate. FY2025 continuing revenue grew 1.9% reported and 1.7% core, while Q1 2026 core growth accelerated to 5.3%. That matters because the Ralliant separation created a cleaner Fortive profile: investors can now judge whether the continuing IOS and AHS businesses can produce consistent core growth without the former Precision Technologies segment.

Which segment is carrying the growth?

Both segments contributed to Q1 2026 growth. IOS revenue was $743M, up 7.6% reported and 5.2% core, with 34.3% adjusted EBITDA margin. AHS revenue was $326M, up 7.9% reported and 5.8% core, with 25.7% adjusted EBITDA margin. IOS remains the larger and more profitable segment, but AHS delivered slightly faster Q1 2026 core growth. For a student or investor, that means the story should not be reduced to "Fluke plus healthcare"; the company needs both the industrial workflow base and the healthcare workflow recovery to sustain the new profile.

How strong are Fortive’s margins, cash flow, and balance sheet?

Fortive's financial profile is the main reason the company deserves a research brief rather than a simple industrial product summary. FY2025 gross margin was 63.5%, operating margin was 17.3%, andadjusted EBITDA margin was 29.6% under the continuing-company presentation in the FY2025 results release. Those are high margins for a business with meaningful hardware exposure, and they reflect brand strength, software/service mix, price realization, and the Fortive Business System operating discipline.

Why are margins central to the story?

The margin story is not risk-free. FY2025 operating margin declined by 30 basis points from FY2024, with pricing and productivity offset by separation-related stock compensation, restructuring, and other costs. Still, Q1 2026 adjusted EBITDA margin expansion suggests management is trying to prove that the new Fortive can generate operating leverage even after the portfolio split.

How much balance-sheet flexibility is available?

At April 3, 2026, Fortive reported $356.1M of cash, $2.59B of long-term debt, $899.8M of current long-term debt, and $6.09B of shareholders' equity. That is not a net-cash balance sheet; capital allocation has to consider maturities, interest expense, and the company's ability to keep generating cash. The offset is that cash conversion has been strong. FY2025 continuing operating cash flow was $1.036B and capital expenditures were $105.1M, producing roughly $930.6M of free cash flow before considering other investing and financing uses. Fortive's FY2025 results release rounded free cash flow to $931M and said the company repurchased $1.6B of shares during FY2025.

What turning points shaped Fortive’s current strategy?

Fortive's history matters because the company is the product of separations, portfolio reshaping, and operating-system discipline. The most useful timeline is not a complete corporate chronology; it is the chain of decisions that explains why today's Fortive is a two-segment workflow company with high margins, meaningful software exposure, and a capital-allocation story centered on cash flow.

What changed after the Danaher spin?

1. 2015-2016
   Fortive was incorporated in 2015 and became an independent public company in July 2016 after its separation from Danaher. That origin explains the continued emphasis on operating discipline and continuous improvement.
2. 2018
   The company agreed to acquire Accruent for about $2.0B in cash, adding facility, asset, and compliance software that broadened Fortive beyond instruments into lifecycle workflow software.
3. 2021
   Fortive announced the acquisition of ServiceChannel for about $1.2B, strengthening contractor-network and facilities-service workflows alongside Accruent and Gordian.
4. 2025
   The Ralliant separation created a cleaner Fortive centered on Intelligent Operating Solutions and Advanced Healthcare Solutions.
5. 2025
   Olumide Soroye became President, CEO, and Director, signaling a new management chapter focused on the post-separation portfolio.
6. 2026
   Q1 2026 showed 5.3% core revenue growth and 29.3% adjusted EBITDA margin, giving investors the first major proof point for the new operating profile.

Why did software acquisitions matter?

The Accruent and ServiceChannel deals matter because they shifted Fortive's center of gravity toward workflow platforms, recurring services, and data-rich customer relationships. The official Accruent acquisition announcement described a roughly $270M revenue software business, while the ServiceChannel announcement described a SaaS platform and contractor network expected to generate about $125M of 2021 revenue. The strategic point is that facilities and asset workflows can expand Fortive's relationship from a tool or instrument sale into recurring operational management.

The Ralliant transaction was the other structural turning point. Fortive's June 2025 separation announcement said Fortive shareholders received one Ralliant share for every three Fortive shares held, with about 113M Ralliant shares distributed. For Fortive analysis, the implication is a narrower company with less precision-technology diversification but a clearer identity around resilient workflows and cash generation.

What gives Fortive a durable competitive advantage?

Fortive's moat is a combination of brand trust, installed workflows, customer switching costs, technical support, and the Fortive Business System. The company says no single patent, trademark, or license is material to the business as a whole, so the advantage is not a single blocking patent. It is more practical: customers use Fortive products and software in environments where errors are costly, records matter, and staff need reliable tools. That creates resistance to switching when the installed base is embedded in training, service routines, calibration, compliance, and purchasing systems.

Where does the moat come from?

This scorecard is an analytical interpretation, not a company rating. The supporting facts are concrete: FY2025 gross margin was 63.5%; FY2025 free cash flow was $931M; Q1 2026 adjusted EBITDA margin was 29.3%; and remaining performance obligations were $840.7M at December 31, 2025. Together, they show that Fortive's competitive position is visible in the income statement and cash-flow statement, not only in brand language.

Competitive pressure. Fortive competes category by category rather than against one exact mirror image. In instrumentation and test tools, it faces established industrial and electronic measurement players; in facility lifecycle software, it competes with specialized asset-management, work-order, and construction-cost platforms; in sterilization and healthcare workflow, it competes with infection prevention, instrument tracking, and clinical documentation providers. Fortive's annual report emphasizes this fragmented reality: it says the company is a leader in many served markets, but no single competitor offers the same complete mix of products, software, services, and end markets.

Who owns Fortive stock, and how does governance matter?

Fortive is not a founder-controlled dual-class story. Its governance is more typical of a mature public company with one listed common stock, annual director elections, institutional ownership, and board oversight of executive compensation and strategy. That matters because the pressure on management is likely to come through institutional voting, capital-allocation expectations, and performance targets rather than through a controlling founder or family block.

What does ownership say about control?

The ownership facts above come from Fortive's Dodge & Cox Schedule 13G/A, Vanguard Capital Management Schedule 13G, and the company's 2026 proxy materials available through the official annual reports and proxy page. The practical conclusion is that Fortive's governance is institutionally influenced: investors will watch whether management converts the post-separation strategy into growth, margins, and per-share cash flow.

How does leadership affect the post-separation story?

Leadership changed at the same time the portfolio changed. Olumide Soroye became President, CEO, and Director in June 2025, while James Lico retired. Fortive's official executive team page describes Soroye as leading the new chapter of profitable growth and value creation after previously leading the IOS and AHS businesses. For analysts, that background is relevant: the CEO is not managing an inherited portfolio from a distance; he has direct operating exposure to the two continuing segments that now define the company.

What opportunities and risks could change Fortive’s outlook?

Fortive's opportunity set is tied to workflow digitization, safety, healthcare productivity, facility lifecycle management, pricing, and operating-system execution. The risk set is equally company-specific: tariff and trade policy uncertainty, healthcare policy changes, cyclicality in industrial capital spending, integration and acquisition execution, software competition, cybersecurity, debt refinancing, goodwill impairment, and separation-related tax or legal complexity. The company is attractive as a case study because the upside and downside both flow through the same mechanism: can Fortive make critical workflows more efficient while preserving pricing and cash conversion?

What opportunities matter most?

What risks are specific to Fortive?

Why does Fortive matter for valuation and DCF analysis?

Fortive is a useful DCF case because the valuation is highly sensitive to a small number of drivers: core revenue growth, adjusted EBITDA margin, free cash flow conversion, debt refinancing cost, share repurchases, and terminal reinvestment needs. A simple revenue multiple misses the business model. A more useful model separates IOS and AHS, estimates the durability of services and software revenue, and tests whether Q1 2026 margin expansion is repeatable or merely boosted by timing and cost actions.

Which KPIs belong in a DCF?

What should researchers monitor next?

What is the key takeaway from Fortive analysis?

Fortive is best understood as a focused workflow technology company with industrial and healthcare roots, not as a generic diversified manufacturer. The 2025 Ralliant separation made the story cleaner: IOS supplies most of the revenue and margin, while AHS adds healthcare workflow exposure that can strengthen resilience if demand improves. The company's strengths are visible in its FY2025 gross margin of 63.5%, FY2025 free cash flow of $931M, Q1 2026 adjusted EBITDA margin of 29.3%, and its mix of software, services, instrumentation, and healthcare workflow assets.

For students, Fortive is a strong case study in portfolio transformation, operating-system advantage, and the shift from product businesses toward workflow ecosystems. For investors and analysts, the central question is whether the new Fortive can convert mid-single-digit core growth into durable free cash flow and per-share value without relying too heavily on repurchases, acquisitions, or short-term margin actions.